Van solo naar symfonie. Grenzen verleggen door samenspel in translationeel onderzoek
Translational research plays a key role in improving outcomes for women with gynecologic cancer. It serves as the bridge between the laboratory and the doctor’s office. This is what Christianne Lok, Professor by Special Appointment of Translational Gynecologic Oncology, states in her inaugural lecture.
Discoveries in the lab are translated into better care for patients, while questions from clinical practice drive new research. Take biomarkers, for example: measurable signals in the body that provide information about disease. They help in making the correct diagnosis and selecting the most appropriate treatment. Among other things, Lok is studying biomarkers in blood to better predict which women with ovarian tumors require specialized care.
In addition, she focuses on rare forms of gynecological cancer. It is precisely these small patient groups that require personalized care. By combining laboratory research with clinical studies, new treatments can be developed. This is how we move from a solo performance to a symphony: through collaboration between researchers, doctors, and patients, we improve care.